Capital DailyCapital Daily
Finance

New drug data makes this French biotech stock a buy, says Jefferies

Analyst Faisal Khurshid upgraded the stock to buy from hold.

New drug data makes this French biotech stock a buy, says Jefferies

Published July 1, 2026 · Category: Finance

Overview

Analyst Faisal Khurshid upgraded the stock to buy from hold.

Source

Originally published at www.cnbc.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.